Menopause in Type 1 Diabetic Women: is It Premature?
Overview
Affiliations
Women with type 1 diabetes have a delayed menarche and a greater prevalence of menstrual disorders than women without diabetes. However, little is known about the menopause transition among type 1 diabetic women. The Familial Autoimmune and Diabetes (FAD) Study recruited both adult individuals who were identified from the Children's Hospital of Pittsburgh Type 1 Diabetes Registry for the years 1950-1964 and their family members. Unrelated nondiabetic control probands and their relatives were also evaluated. Women with type 1 diabetes (n = 143) compared with nondiabetic sisters (n = 186) or unrelated control subjects (n = 160) were more likely to have an older age at menarche (13.5, 12.5, and 12.6 years, respectively, P < 0.001), more menstrual irregularities before 30 years of age (45.7, 33.3, and 33.1%, respectively, P = 0.04), and a younger age at menopause (41.6, 49.9, and 48.0 years, respectively, P = 0.05). This resulted in a 6-year reduction in the number of reproductive years (30.0, 37.0, and 35.2 years, respectively, P = 0.05) for women with type 1 diabetes. Risk factors univariately associated with earlier menopause included type 1 diabetes (hazard ratio [HR] 1.99, P = 0.04), menstrual irregularities before 30 years of age (HR 1.87, P = 0.04), nulliparity (HR 2.14, P = 0.01), and unilateral oophorectomy (HR 6.51, P < 0.0001). Multivariate analysis confirmed that type 1 diabetes (HR 1.98, P = 0.056), menstrual irregularities by 30 years of age (HR 2.36, P = 0.01), and unilateral oophorectomy (HR 9.76, P < 0.0001) were independent determinants of earlier menopause in our cohort. We hypothesize that an earlier menopause, which resulted in a 17% decrease in reproductive years, is a major unstudied complication of type 1 diabetes.
Lebkowska A, Krentowska A, Adamska A, Uruska A, Rogowicz-Frontczak A, Araszkiewicz A Sci Rep. 2024; 14(1):13223.
PMID: 38851814 PMC: 11162496. DOI: 10.1038/s41598-024-63741-1.
Gonadal dysfunction in women with diabetes mellitus.
Zaimi M, Michalopoulou O, Stefanaki K, Kazakou P, Vasileiou V, Psaltopoulou T Endocrine. 2024; 85(2):461-472.
PMID: 38353886 PMC: 11291547. DOI: 10.1007/s12020-024-03729-z.
Mehri K, Hamidian G, Oskuye Z, Nayebirad S, Farajdokht F Front Endocrinol (Lausanne). 2023; 14:1193150.
PMID: 37424869 PMC: 10324965. DOI: 10.3389/fendo.2023.1193150.
Blonde L, Umpierrez G, Reddy S, McGill J, Berga S, Bush M Endocr Pract. 2022; 28(10):923-1049.
PMID: 35963508 PMC: 10200071. DOI: 10.1016/j.eprac.2022.08.002.
The interplay between diabetes mellitus and menopause: clinical implications.
Lambrinoudaki I, Paschou S, Armeni E, Goulis D Nat Rev Endocrinol. 2022; 18(10):608-622.
PMID: 35798847 DOI: 10.1038/s41574-022-00708-0.